Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation

被引:0
|
作者
Ray, Wayne A. [1 ]
Murray, Katherine T. [2 ]
机构
[1] Vanderbilt Univ, Dept Hlth Policy, Sch Med, Nashville, TN USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA
来源
关键词
D O I
10.1001/jama.2022.1425
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1290 / 1290
页数:1
相关论文
共 50 条
  • [31] Comparative Effectiveness of Dabigatran, Rivaroxaban, Apixaban, and Warfarin in the Management of Patients With Nonvalvular Atrial Fibrillation
    Pink, J.
    Pirmohamed, M.
    Hughes, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) : 269 - 276
  • [32] Early apixaban therapy after ischemic stroke in patients with atrial fibrillation
    Anas Alrohimi
    Brian Buck
    Glen Jickling
    Ashfaq Shuaib
    Sibi Thirunavukkarasu
    Ken S. Butcher
    Journal of Neurology, 2021, 268 : 1837 - 1846
  • [33] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack
    Coleman, Craig I.
    Peacock, W. Frank
    Bunz, Thomas J.
    Alberts, Mark J.
    STROKE, 2017, 48 (08) : 2142 - +
  • [34] Early apixaban therapy after ischemic stroke in patients with atrial fibrillation
    Alrohimi, Anas
    Buck, Brian
    Jickling, Glen
    Shuaib, Ashfaq
    Thirunavukkarasu, Sibi
    Butcher, Ken S.
    JOURNAL OF NEUROLOGY, 2021, 268 (05) : 1837 - 1846
  • [35] Pharmacoeconomic aspects of apixaban for prevention of thromboembolic events in patients with atrial fibrillation
    Rudakova, A. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (01) : 60 - 62
  • [36] New Anticoagulants (Dabigatran, Apixaban, Rivaroxaban) for Stroke Prevention in Atrial Fibrillation
    Aguilar, Maria I.
    Kuo, Ruth S.
    Freeman, William D.
    NEUROLOGIC CLINICS, 2013, 31 (03) : 659 - +
  • [37] COST EFFECTIVENESS OF APIXABAN, DABIGATRAN RIVAROXABAN AND WARFARIN FOR ATRIAL FIBRILLATION IN GUATEMALA
    Garita, M.
    Peralta, M.
    Gordillo, D., I
    VALUE IN HEALTH, 2014, 17 (03) : A115 - A115
  • [38] HEMORRHAGIC VERSUS ISCHEMIC RISK IN PATIENTS WITH ATRIAL FIBRILLATION ON HEMODIALYSIS
    Sousa, Mariana
    Bravo, Pedro
    Santos, Cristina
    Ramos, Aura
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1630 - 1630
  • [39] Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice A Cohort Study
    Fralick, Michael
    Colacci, Michael
    Schneeweiss, Sebastian
    Huybrechts, Krista F.
    Lin, Kueiyu Joshua
    Gagne, Joshua J.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - +
  • [40] Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation
    Mamas, Mamas A.
    Batson, Sarah
    Pollock, Kevin G.
    Grundy, Sarah
    Matthew, Andrew
    Chapman, Chris
    Manuel, Joana Assis
    Farooqui, Usman
    Mitchell, Stephen A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 166 : 58 - 64